Company announcements

Announcement type

All

Price-sensitive

Stock code or name

leave blank for all companies

Headline

leave blank for all announcements

Sector

Market Cap ($m)

Announcement date

View top

announcements

Order By

Ascending

Descending

Reset Filters

Search Results

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Response to ASX Price Query	25 Oct 2012 9:38AM	$0.037	$16.950	risen by 45,710.81%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Half Yearly Report and Accounts	30 Aug 2012 11:22AM	$0.023	$16.950	risen by 73,595.65%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Appendix 4C - quarterly	31 Jul 2012 9:22AM	$0.023	$16.950	risen by 73,595.65%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren awarded Rett Syndrome trial grant	6 Jul 2012 1:45PM	$0.024	$16.950	risen by 70,525%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren announces cancer xenograft testing results	29 May 2012 10:10AM	$0.025	$16.950	risen by 67,700%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Rett Syndrome pre-IND meeting held with FDA	16 May 2012 9:34AM	$0.025	$16.950	risen by 67,700%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Appendix 4C - quarterly	30 Apr 2012 8:53AM	$0.025	$16.950	risen by 67,700%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Response to ASX Price Query	19 Apr 2012 2:41PM	$0.028	$16.950	risen by 60,435.71%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren 2011 Preliminary Final Report	29 Feb 2012 9:53AM	$0.024	$16.950	risen by 70,525%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Appendix 4C - quarterly	31 Jan 2012 12:53PM	$0.026	$16.950	risen by 65,092.31%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren to proceed with oral NNZ2566 trial	22 Dec 2011 12:21PM	$0.026	$16.950	risen by 65,092.31%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Response to ASX Price Query	9 Dec 2011 1:55PM	$0.030	$16.950	risen by 56,400%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren Completes Phase II trial Cohort 2	21 Nov 2011 8:26AM	$0.029	$16.950	risen by 58,348.28%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Appendix 4C - quarterly	28 Oct 2011 10:11AM	$0.033	$16.950	risen by 51,263.64%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Response to ASX Price Query	20 Oct 2011 2:13PM	$0.024	$16.950	risen by 70,525%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Half Yearly Report and Accounts	30 Aug 2011 9:12AM	$0.017	$16.950	risen by 99,605.88%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren places $3m of rights issue shortfall	16 Aug 2011 8:54AM	$0.016	$16.950	risen by 105,837.50%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Appendix 4C - quarterly	29 Jul 2011 12:05PM	$0.017	$16.950	risen by 99,605.88%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren Rights Issue Letter of Offer (Australian residents)	15 Jun 2011 8:29AM	$0.017	$16.950	risen by 99,605.88%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren Rights Issue Offer Document (NZ residents)	15 Jun 2011 8:29AM	$0.017	$16.950	risen by 99,605.88%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren announces Renounceable Rights Issue	15 Jun 2011 8:27AM	$0.017	$16.950	risen by 99,605.88%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren reduces outstanding convertible note principal	20 May 2011 2:22PM	$0.021	$16.950	risen by 80,614.29%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren`s Perseis selects lead antibodies	19 May 2011 10:01AM	$0.020	$16.950	risen by 84,650%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren Completes Phase II trial Cohort 1	11 May 2011 10:40AM	$0.019	$16.950	risen by 89,110.53%
Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID	Health Care	$2,149	Neuren Announces Private Placement and Rights Issue	4 May 2011 9:51AM	$0.014	$16.950	risen by 120,971.43%

676 - 700 of 821 results

Page 28 of 33

+ Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.